Cipla (NSE:CIPLA) Short Interest


NSE:CIPLA Cipla Ltd NSE:CIPLA
94 GF Score
Price ₹1,437.90
GF Value ₹1,567.62
Valuation Fairly Valued
! 3 Warning Signs
View Full Analysis

What is Cipla Short Interest?

Short Interest can be expressed as a percentage by dividing the number of shares sold short by the total number of outstanding shares.

Due to the license agreement change with our data vendor, Short Interest related data on GuruFocus will no longer be updated. Existing data will remain as-is, while new data will not be available, except for certain Australian and Canadian stocks.

NSE:CIPLA vs ZTS: Short Interest Comparison

For the Drug Manufacturers - Specialty & Generic subindustry, Cipla's Short Interest, along with its competitors' market caps and Short Interest data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Cipla Short Interest vs Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Cipla's Short Interest distribution charts can be found below:

* The bar in red indicates where Cipla's Short Interest falls into.


NSE:CIPLA
94GF Score
Cipla Ltd NSE:CIPLA
Short Interest is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is Cipla (NSE:CIPLA) Overvalued in 2026?

Based on GuruFocus' analysis, Cipla stock appears to be undervalued. The current stock price of ₹1,437.90 is trading 8.3% below its estimated GF Value™ of ₹1,567.62. GuruFocus considers Cipla to be Fairly Valued.

Key valuation signals for NSE:CIPLA:

  • Short Interest:
  • GF Value™: ₹1,567.62 vs. price of ₹1,437.90 (8.3% below fair value)
  • GF Score™: 94/100 with 3 warning signs

No single metric tells the full story. See the NSE:CIPLA stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Cipla Business Description

Other Exchanges 500087:India
Address Ganpatrao Kadam Marg, Cipla House, Peninsula Business Park, Lower Parel, Mumbai, MH, IND, 400 013
Cipla Ltd is a drug manufacturing company that focuses on a variety of pharmaceutical products. The company's product portfolio spans complex generics as well as drugs in the respiratory, anti-retroviral, urology, cardiology, anti-infective, CNS, and various other key therapeutic segments. The bulk of its sales are generated in India, although it maintains a large world-wide presence. Cipla's growth plan focuses on new product launches. It has two segments Pharmaceuticals and new ventures. It derives maximum revenue from Pharmaceuticals Segment.
94GF Score

Get the complete analysis for NSE:CIPLA

Short Interest is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₹1,437.90
Price
₹1,567.62
GF Value